Semmelweis Publications
  • Main page

    • Department of Internal Medicine and Oncology - Highly cited papers

    Below listed the publications of the university which are currently qualified as "Highly Cited" in Web of Science database

    Order by:
    SU Authorship:
    Number of publications: 18
    1.
    ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
    Raine, T;Bonovas, S;Burisch, J;Kucharzik, T;Adamina, M;Annese, V;Bachmann, O;Bettenworth, D;Chaparro, M;Czuber-Dochan, W;Eder, P;Ellul, P;Fidalgo, C;Fiorino, G;Gionchetti, P;Gisbert, JP;Gordon, H;Hedin, C;Holubar, S;Iacucci, M;Karmiris, K;Katsanos, K;Kopylov, U;Lakatos, PL;Lytras, T;Lyutakov, I;Noor, N;Pellino, G;Piovani, D;Savarino, E;Selvaggi, F;Verstockt, B;Spinelli, A;Panis, Y;Doherty, G
    JOURNAL OF CROHNS & COLITIS
    2022.
    DOI:10.1093/ecco-jcc/jjab178 (Copy DOI)
    Semmelweis University authors: Lakatos, Péter László,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    2.
    EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
    Fanouriakis, A;Kostopoulou, M;Andersen, J;Aringer, M;Arnaud, L;Bae, SC;Boletis, J;Bruce, IN;Cervera, R;Doria, A;Doerner, T;Furie, RA;Gladman, DD;Houssiau, FA;Inês, LS;Jayne, D;Kouloumas, M;Kovács, L;Mok, CC;Morand, EF;Moroni, G;Mosca, M;Mucke, J;Mukhtyar, CB;Nagy, G;Navarra, S;Parodis, I;Pego-Reigosa, JM;Petri, M;Pons-Estel, BA;Schneider, M;Smolen, JS;Svenungsson, E;Tanaka, Y;Tektonidou, MG;Teng, YO;Tincani, A;Vital, EM;van Vollenhoven, RF;Wincup, C;Bertsias, G;Boumpas, DT
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2024.
    DOI:10.1136/ard-2023-224762 (Copy DOI)
    3.
    ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
    Spinelli, A;Bonovas, S;Burisch, J;Kucharzik, T;Adamina, M;Annese, V;Bachmann, O;Bettenworth, D;Chaparro, M;Czuber-Dochan, W;Eder, P;Ellul, P;Fidalgo, C;Fiorino, G;Gionchetti, P;Gisbert, JP;Gordon, H;Hedin, C;Holubar, S;Iacucci, M;Karmiris, K;Katsanos, K;Kopylov, U;Lakatos, P;Lytras, T;Lyutakov, I;Noor, N;Pellino, G;Piovani, D;Savarino, E;Selvaggi, F;Verstockt, B;Doherty, G;Raine, T;Panis, Y
    JOURNAL OF CROHNS & COLITIS
    2022.
    DOI:10.1093/ecco-jcc/jjab177 (Copy DOI)
    Semmelweis University authors: Lakatos, Péter László,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    4.
    Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
    Mateos, MV;Cavo, M;Blade, J;Dimopoulos, MA;Suzuki, K;Jakubowiak, A;Knop, S;Doyen, C;Lucio, P;Nagy, Z;Pour, L;Cook, M;Grosicki, S;Crepaldi, A;Liberati, AM;Campbell, P;Shelekhova, T;Yoon, SS;Iosava, G;Fujisaki, T;Garg, M;Krevvata, M;Chen, Y;Wang, JP;Kudva, A;Ukropec, J;Wroblewski, S;Qi, M;Kobos, R;San-Miguel, J
    D1
    LANCET
    2020.
    DOI:10.1016/S0140-6736(19)32956-3 (Copy DOI)
    Semmelweis University authors: Nagy, Zsolt,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    5.
    Association Between Age at Diabetes Onset and Subsequent Risk of Dementia
    Amidei, CB;Fayosse, A;Dumurgier, J;Machado-Fragua, MD;Tabak, AG;van Sloten, T;Kivimäki, M;Dugravot, A;Sabia, S;Singh-Manoux, A
    D1
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    2021.
    DOI:10.1001/jama.2021.4001 (Copy DOI)
    6.
    Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
    Salles, G;Duell, J;Barca, EG;Tournilhac, O;Jurczak, W;Liberati, AM;Nagy, Z;Obr, A;Gaidano, G;André, M;Kalakonda, N;Dreyling, M;Weirather, J;Dirnberger-Hertweck, M;Ambarkhane, S;Fingerle-Rowson, G;Maddocks, K
    D1
    LANCET ONCOLOGY
    2020.
    DOI:10.1016/S1470-2045(20)30225-4 (Copy DOI)
    Semmelweis University authors: Nagy, Zsolt,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    7.
    EULAR definition of difficult-to-treat rheumatoid arthritis
    Nagy, G;Roodenrijs, NMT;Welsing, PMJ;Kedves, M;Hamar, A;van der Goes, MC;Kent, A;Bakkers, M;Blaas, E;Senolt, L;Szekanecz, Z;Choy, E;Dougados, M;Jacobs, JWG;Geenen, R;Bijlsma, HWJ;Zink, A;Aletaha, D;Schoneveld, L;van Riel, P;Gutermann, L;Prior, Y;Nikiphorou, E;Ferraccioli, G;Schett, G;Hyrich, KL;Mueller-Ladner, U;Buch, MH;McInnes, IB;van der Heijde, D;van Laar, JM
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2021.
    DOI:10.1136/annrheumdis-2020-217344 (Copy DOI)
    8.
    Formation of a protein corona on the surface of extracellular vesicles in blood plasma
    Tóth, EA;Turiák, L;Visnovitz, T;Cserép, C;Mázló, A;Sódar, BW;Forsonits, AI;Petovári, G;Sebestyén, A;Komlósi, Z;Drahos, L;Kittel, A;Nagy, G;Bácsi, A;Dénes, A;Gho, YS;Szabó-Taylor, KÉ;Buzas, EI
    D1
    JOURNAL OF EXTRACELLULAR VESICLES
    2021.
    DOI:10.1002/jev2.12140 (Copy DOI)
    9.
    EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
    Nagy, G;Roodenrijs, NMT;Welsing, PMJ;Kedves, M;Hamar, A;van der Goes, MC;Kent, A;Bakkers, M;Pchelnikova, P;Blaas, E;Senolt, L;Szekanecz, Z;Choy, EH;Dougados, M;Jacobs, JWG;Geenen, R;Bijlsma, JWJ;Zink, A;Aletaha, D;Schoneveld, L;van Riel, P;Dumas, S;Prior, Y;Nikiphorou, E;Ferraccioli, G;Schett, G;Hyrich, KL;Mueller-Ladner, U;Buch, MH;McInnes, IB;van der Heijde, D;van Laar, JM
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2022.
    DOI:10.1136/annrheumdis-2021-220973 (Copy DOI)
    10.
    The Burden of Inflammatory Bowel Disease in Europe in 2020
    Zhao, M;Gönczi, L;Lakatos, PL;Burisch, J
    D1
    JOURNAL OF CROHNS & COLITIS
    2021.
    DOI:10.1093/ecco-jcc/jjab029 (Copy DOI)
    11.
    Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
    Wagner, R;Heni, M;Tabák, AG;Machann, J;Schick, F;Randrianarisoa, E;de Angelis, MH;Birkenfeld, AL;Stefan, N;Peter, A;Häring, HU;Fritsche, A
    D1
    NATURE MEDICINE
    2021.
    DOI:10.1038/s41591-020-1116-9 (Copy DOI)
    12.
    Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study
    Burisch, J;Kiudelis, G;Kupcinskas, L;Kievit, HAL;Andersen, KW;Andersen, V;Salupere, R;Pedersen, N;Kjeldsen, J;D'Incà, R;Valpiani, D;Schwartz, D;Odes, S;Olsen, J;Nielsen, KR;Vegh, Z;Lakatos, PL;Toca, A;Turcan, S;Katsanos, KH;Christodoulou, DK;Fumery, M;Gower-Rousseau, C;Zammit, SC;Ellul, P;Eriksson, C;Halfvarson, J;Magro, FJ;Duricova, D;Bortlik, M;Fernandez, A;Hernandez, V;Myers, S;Sebastian, S;Oksanen, P;Collin, P;Goldis, A;Misra, R;Arebi, N;Kaimakliotis, IP;Nikuina, I;Belousova, E;Brinar, M;Cu...
    D1
    GUT
    2019.
    DOI:10.1136/gutjnl-2017-315568 (Copy DOI)
    13.
    The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
    Burisch, J;Zhao, M;Odes, S;De Cruz, P;Vermeire, S;Bernstein, CN;Kaplan, GG;Duricova, D;Greenberg, D;Melberg, HO;Watanabe, M;Ahn, HS;Targownik, L;Pittet, VEH;Annese, V;Park, KT;Katsanos, KH;Hoivik, ML;Krznaric, Z;Chaparro, M;Loftus, EV;Lakatos, PL;Gisbert, JP;Bemelman, W;Moum, B;Gearry, RB;Kappelman, MD;Hart, A;Pierik, MJ;Andrews, JM;Ng, SC;D'Inca, R;Munkholm, P
    D1
    LANCET GASTROENTEROLOGY & HEPATOLOGY
    2023.
    DOI:10.1016/S2468-1253(23)00003-1 (Copy DOI)
    Semmelweis University authors: Lakatos, Péter László,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    14.
    Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations
    Ziegler, D;Tesfaye, S;Spallone, V;Gurieva, I;Al Kaabi, J;Mankovsky, B;Martinka, E;Radulian, G;Nguyen, KT;Stirban, AO;Tankova, T;Varkonyi, T;Freeman, R;Kempler, P;Boulton, AJM
    D1
    DIABETES RESEARCH AND CLINICAL PRACTICE
    2022.
    DOI:10.1016/j.diabres.2021.109063 (Copy DOI)
    Semmelweis University authors: Kempler, Péter,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    15.
    Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency: A Central and Eastern European Expert Consensus Statement
    Pludowski, P;Takacs, I;Boyanov, M;Belaya, Z;Diaconu, CC;Mokhort, T;Zherdova, N;Rasa, I;Payer, J;Pilz, S
    D1
    NUTRIENTS
    2022.
    DOI:10.3390/nu14071483 (Copy DOI)
    Semmelweis University authors: Takács, István,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    16.
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
    Wanner, C;Inzucchi, SE;Lachin, JM;Fitchett, D;von Eynatten, M;Mattheus, M;Johansen, OE;Woerle, HJ;Broedl, UC;Zinman, B;Aizenberg, D;Ulla, M;Waitman, J;De Loredo, L;Farías, J;Fideleff, H;Lagrutta, M;Maldonado, N;Colombo, H;Pacora, FF;Wasserman, A;Maffei, L;Lehman, R;Selvanayagam, J;d'Emden, M;Fasching, P;Paulweber, B;Toplak, H;Luger, A;Drexel, H;Prager, R;Schnack, C;Schernthaner, G;Fliesser-Görzer, E;Kaser, S;Scheen, A;Van Gaal, L;Hollanders, G;Kockaerts, Y;Capiau, L;Chachati, A;Persu, A;Herman...
    D1
    NEW ENGLAND JOURNAL OF MEDICINE
    2016.
    DOI:10.1056/NEJMoa1515920 (Copy DOI)
    17.
    Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial
    Fitchett, D;Zinman, B;Wanner, C;Lachin, JM;Hantel, S;Salsali, A;Johansen, OE;Woerle, HJ;Broedl, UC;Inzucchi, SE;Aizenberg, D;Ulla, M;Waitman, J;De Loredo, L;Farías, J;Fideleff, H;Lagrutta, M;Maldonado, N;Colombo, H;Pacora, FF;Wasserman, A;Maffei, L;Lehman, R;Selvanayagam, J;d'Emden, M;Fasching, P;Paulweber, B;Toplak, H;Luger, A;Drexel, H;Prager, R;Schnack, C;Schernthaner, G;Fliesser-Görzer, E;Kaser, S;Scheen, A;Van Gaal, L;Hollanders, G;Kockaerts, Y;Capiau, L;Chachati, A;Persu, A;Hermans, M;Va...
    D1
    EUROPEAN HEART JOURNAL
    2016.
    DOI:10.1093/eurheartj/ehv728 (Copy DOI)
    18.
    Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial
    Rosenstock, J;Perkovic, V;Johansen, OE;Cooper, ME;Kahn, SE;Marx, N;Alexander, JH;Pencina, M;Toto, RD;Wanner, C;Zinman, B;Woerle, HJ;Baanstra, D;Pfarr, E;Schnaidt, S;Meinicke, T;George, JT;von Eynatten, M;McGuire, DK;Aizenberg, D;Fiorella, A;Edgardo, N;Belen, CI;Alonso, P;Walter, M;Maia, K;Guillermo, S;Leandro, B;Constanza, RM;Alejandra, NM;Melina, C;Ariel, IL;Martin, S;Rodrigo, C;Alvarez, C;Jorge, MZ;Gabriel, C;German, S;Bartolacci, I;Bolobanich, GA;Tale, T;Meritano, M;Echeverria, MG;Gerrini, SP...
    D1
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    2019.
    DOI:10.1001/jama.2018.18269 (Copy DOI)

    Navigation

    Main page

    Publication search

    Department ranking

    Author ranking

    Author search

    Articles recently published in SJR D1 journals

    Top papers of the university

    Top field weighted citation impact publications

    Highly Cited Articles of Semmelweis University

    Semmelweis Publications
    Release: 2025_2
    Department data last refreshed at: 04.02.2025
    Author data last refreshed at: 04.02.2025
    (c) Semmelweis University - Central Library